- Home
- SPNT vs ATAI Comparison
SPNT vs ATAI Comparison
Compare SPNT & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SPNT | ATAI |
|---|---|---|
| Founded | 2011 | 2018 |
| Country | Bermuda | United States |
| Employees | 1099 | N/A |
| Industry | Property-Casualty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.6B |
| IPO Year | N/A | 2025 |
Fundamental Metrics
Financial Performance| Metric | SPNT | ATAI |
|---|---|---|
| Price | $24.44 | $7.17 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $27.50 | $15.88 |
| AVG Volume (30 Days) | 888.8K | ★ 10.4M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $4,089,000.00 |
| Revenue This Year | $0.85 | N/A |
| Revenue Next Year | $5.85 | N/A |
| P/E Ratio | $5.65 | ★ N/A |
| Revenue Growth | N/A | ★ 1227.60 |
| 52 Week Low | $17.17 | $3.06 |
| 52 Week High | $25.40 | $7.22 |
Technical Indicators
Market Signals| Indicator | SPNT | ATAI |
|---|---|---|
| Relative Strength Index (RSI) | 55.16 | 73.35 |
| Support Level | $22.18 | $3.56 |
| Resistance Level | N/A | N/A |
| Average True Range (ATR) | 0.64 | 0.36 |
| MACD | -0.03 | 0.22 |
| Stochastic Oscillator | 45.35 | 97.55 |
Price Performance
Historical ComparisonAbout SPNT SiriusPoint Ltd.
SiriusPoint Ltd provides property and casualty reinsurance coverage to insurance and reinsurance companies in the United States, Canada, Bermuda, the United Kingdom, and Europe. The company operates through two operating segments: Reinsurance and Insurance & Services. The company's product portfolio consists of reinsurance contracts for property insurance including both residential and commercial properties, workers' compensation, personal automobile, businesses' general liability insurance, professional liability insurance to protect professional advisors and service providers, agriculture insurance, and mortgage insurance. The majority of the revenue is generated from its Insurance & Services segment.
About ATAI ATAI Life Sciences N.V.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.